Sponsor or institution

Clinical trials and research at ANRS, Emerging Infectious Diseases

• 16Clinical trials
• 16Countries

Newest trials

All recruiting trials (16)

• booster vaccines for adults previously vaccinated against COVID-19

  This trial tests two new vaccine boosters against the two approved boosters in healthy adults aged 18–65 who previously received mRNA vaccines.

  Recruiting at 3 sites Early Phase 1 ANRS, Emerging Infectious Diseases · Créteil and 2 other locations · NCT07605520

• Frailty and aging with HIV in West Africa

  This study tests how frailty and other aging-related health issues appear in older adults with HIV and in similar-aged HIV-uninfected people in West Africa.

  Recruiting ANRS, Emerging Infectious Diseases · Bobo-Dioulasso and 5 other locations · NCT07355413

• HBV Universal vs Point-of-Ccare Antiviral Prophylaxis to Prevent Mother-to-Child Transmission

  This trial tests whether giving antiviral prophylaxis to all HBsAg-positive pregnant women is as effective as a selective approach guided by a rapid HBcrAg test in preventing mother-to-child transmission of hepatitis B.

  Recruiting ANRS, Emerging Infectious Diseases · Haiphong · NCT07054359

• Tuberculosis treatment pathways and outcomes in France: a national cohort

  This French national cohort follows adults starting tuberculosis treatment to see how sociodemographic, clinical, and biological factors relate to treatment outcomes and relapse over 24 months.

  Recruiting ANRS, Emerging Infectious Diseases · Paris and 1 other locations · NCT06893757

• Comparing an intranasal COVID-19 vaccine to an mRNA booster in healthy adults

  This study is testing a new intranasal COVID-19 vaccine to see if it works as well as a standard mRNA booster in healthy adults.

  Recruiting Phase 1/2 ANRS, Emerging Infectious Diseases · Dijon and 4 other locations · NCT06821126

• HPV molecular patterns linked to high-grade anal lesions and cancer in former IPERGAY participants

  This project will test whether specific HPV molecular signatures predict high-grade anal lesions or anal cancer in people who were part of the IPERGAY HPV substudy about 10 years earlier.

  Recruiting at 3 sites ANRS, Emerging Infectious Diseases · Lyon and 2 other locations · NCT06522256

• Testing a new COVID-19 vaccine booster for safety and immune response

  This study is testing a new COVID-19 vaccine booster to see if it’s safe and helps healthy people build a strong immune response compared to an approved vaccine.

  Recruiting at 2 sites Phase 1/2 ANRS, Emerging Infectious Diseases · Créteil and 1 other locations · NCT06255626

• Comparing doravirine and dolutegravir for treating HIV-1 in new patients

  This study is testing if a new HIV treatment called doravirine works just as well as the standard treatment dolutegravir for people who are starting their first HIV therapy.

  Recruiting at 18 sites Phase 3 ANRS, Emerging Infectious Diseases · Nova Iguaçu, Rio de Janeiro and 18 other locations · NCT06203132

• Evaluating on-demand HIV prevention in men who have sex with men in Thailand and France

  This study is testing a new on-demand HIV prevention method for men who have sex with men in Thailand and France to see if it works better than the current standard treatment.

  Recruiting at 6 sites Phase 3 ANRS, Emerging Infectious Diseases · Paris and 5 other locations · NCT05813964

• Community-based intervention to reduce tuberculosis among people who inject drugs in Vietnam

  This study is testing a new community program to help reduce tuberculosis among people who inject drugs in Hai Phong, Vietnam, by improving access to care and support.

  Recruiting at 2 sites ANRS, Emerging Infectious Diseases · Haiphong and 1 other locations · NCT05655702

• Using adalimumab to improve survival in HIV patients with tuberculosis meningitis

  This study is testing if adding a medication called adalimumab to the usual treatment can help HIV patients with tuberculosis meningitis live longer and stay safe.

  Recruiting Phase 2 ANRS, Emerging Infectious Diseases · Rio de Janeiro and 2 other locations · NCT05590455

• Optimizing antiviral therapy for immunocompromised patients with COVID-19

  This study is testing if a combination of two antiviral medications can help immunocompromised patients with mild COVID-19 feel better and if taking one of the medications for longer makes a difference.

  Recruiting at 18 sites Phase 2 ANRS, Emerging Infectious Diseases · Bordeaux, Bordeaux and 17 other locations · NCT05587894

• Testing antibodies with ART for early HIV infection

  This study is testing whether a new combination of long-acting antibodies and HIV medication can help people with early HIV infection control the virus better after stopping the medication.

  Recruiting at 16 sites Phase 2 ANRS, Emerging Infectious Diseases · Bobigny and 16 other locations · NCT05300035

• Observational study of patients co-infected with Hepatitis B and Delta viruses

  This study looks at patients who have both Hepatitis B and Delta viruses to see how their treatment affects their health over time.

  Recruiting at 36 sites ANRS, Emerging Infectious Diseases · Angers and 37 other locations · NCT04166266

• Intensified treatment for tuberculous meningitis to reduce mortality

  This study is testing if a stronger treatment for tuberculous meningitis can help people survive better than the standard treatment.

  Recruiting at 10 sites Phase 3 ANRS, Emerging Infectious Diseases · Abidjan and 12 other locations · NCT04145258

• ANRS CODEX 'Extreme' cohort of people who naturally control HIV

  This project tests blood markers in adults with long-term HIV control without antiretroviral therapy to learn what helps their immune system keep the virus in check.

  Recruiting ANRS, Emerging Infectious Diseases · Le Kremlin-Bicêtre · NCT01520844

Quick answers

How many clinical trials run by ANRS, Emerging Infectious Diseases are recruiting right now?

16, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 16 countries. The most sites are in France (11 trials), Côte d’Ivoire (3 trials), Vietnam (2 trials), Brazil (2 trials), Mozambique (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 3, Phase 3: 3, Phase 1/2: 2, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →